Adopt a Researcher
The “Adopt A Researcher” Project provides financial support for young research doctors with promising futures who work in hospitals while performing innovative research in laboratories.
The idea is to enable donors to adopt a young research doctor; to learn about their areas of activity and to develop a connection with them and their work, which combines both clinical work and laboratory research.
The “Adopt a Researcher” Project was created by the Tel Aviv Sourasky Medical Center to encourage and to foster the quality of the finest researchers and to keep the best minds within the Medical Center. Our goal is to bring back home Israeli doctors and researchers that are currently working in labs and research centers abroad. Tel Aviv Sourasky is proud to be combining medical excellence with Zionism.
The cost of adopting a researcher (for three years) stands at $50,000 US per year (it is possible to divide the cost amongst an unlimited amount of donors).
To donate to this program, click here.
Already a number of young doctors have been adopted through the “Adopt a Researcher” program:
Dr. Uri Arad: The interaction between galectin-3 and Toll-like receptors in the pathogenesis of inflammatory arthritis
|
Dr. Uri Arad is a Senior Doctor in the Rheumatology Institute.
Specialties/ Sub Specialties: Internal Medicine, Rheumatology.
About the Research:
The aim of the research project is to investigate the mechanisms that lead to activation of "danger signal" receptors that lead to propagation of inflammatory responses in arthritis.
|
|
|
Dr. Elissa Ash: Developing Biomarkers and Innovative Diagnostic Tools for Cognitive Disorders |
|
Dr. Ash is the head of the Center for Memory and Concentration Disorders in the Department of Neurology.
Specialties/ Sub Specialties: Memory Disorders and Behavioral Neurology.
About the Research:
The research focuses on the development of biomarkers that are used as innovative diagnostic tools for cognitive decline. The aim of the research is to use functional imaging techniques to develop specific markers that can be used to identify people who are at high risk for developing Alzheimer’s disease prior to onset of significant brain degeneration in order to develop better treatment and prevention strategies.
|
|
| | |
Dr. Ronen Ben-Ami: Understanding the Causes of Violence by Invasive Fungi
|
Dr. Ben-Ami is a Senior Doctor in the Department of Infectious Diseases
Specialties/ Sub Specialties: Internal Medicine and Infectious Diseases. Specializes in Internal Medicine in the Tel Aviv Medical Center and in Mount Sinai Hospital in New York, and completed an internship in Infectious Diseases at the Tel Aviv Medical Center.
About the Research:
Dr. Ben-Ami aims to understand the causes of invasive fungal infections and the interactions that exist between these microorganisms and the human immune system.
His research focuses on the mold Aspergillus fumigatus, which causes pulmonary infection in patients with weakened immune systems, such as those treated for cancer and transplant recipients, and Candida species, which are frequent causes of bloodstream infection in hospitalized patients. Invasive fungal infections are associated with unacceptably high mortality rates, and novel therapeutics are therefore urgently needed.
The research of Dr. Ben-Ami has earned him a number of prizes, including scholarships from The National Institutes of Health and the Israeli Science Foundation. |
|
| |
Dr. Guy Lahat: Identifying Molecular Predictors of Pancreatic Cancer Development and Progression
|
Dr. Lahat is a Senior Doctor in the Surgical Division.
Specialties/ Sub-specialties: General Surgery and Surgical Oncology, Post-doctoral Research Fellow in the MD Anderson Cancer Center, Houston, Texas (2007-2009)
About the Research:
Dr. Lahat’s research is intended to detect specific molecular markers suggestive of malignant transformation of pre-cancerous tumors of the pancreas; such markers would hopefully enable early diagnosis and treatment in order to increase pancreatic cancer cure rates. |
|
| |
Dr. Revital Kariv: Study of Colon Cancer and Other Types of Cancer
|
Dr. Kariv, Specialties/ Sub Specialties: Internal Medicine, Gastroenterology and Liver Diseases
About the Research:
The research of Dr. Kariv focuses on the metastatic process of Colon Cancer; Familial Genetic Syndromes, identification of high risk groups for Colon Cancer and other types of gastrointestinal Cancer; bacterial population of the large bowel and the connection to neoplastic processes.
Dr. Kariv did her research and clinical fellowship in Cleveland, Ohio (Cleveland Clinic and Case University), and earned a number of prizes and scholarships based on her research. |
|
| |
Dr. Amir Shlomai: Finding Innovative Ways to Cure Hepatitis B Virus
|
Dr. Shlomai is aFellow Physician at the Institute for Digestive and Liver Disease
Specialties/ Sub Specialties: Internal Medicine and Gastroenterology
About the Research:
The research of Dr. Shlomai focuses on finding innovative ways to cure Hepatitis B as well as understanding the molecular basis of the interactions between the virus and its host, the liver cell.
The research was started at the Weizman Institute of Science and continued at the Tel Aviv Medical Center. |
|
| |
List of Researchers Still Available for Adoption:
Professor Ziv Gil: The Influence of Cellular Environment on the Development of Cancer
|
Professor Gil is the Director of the Head and Neck Surgery Unit and Head of the Laboratory for Applied Cancer Research.
Specialties/ Sub Specialties: Trained at Memorial Sloan Kettering Cancer Center and University of Pittsburgh School of Medicine. Surgery and Oncology, the Tel Aviv Medical Center expert in Head and Neck Surgery and Skull Base Surgery.
About the Research:
The research focuses on deciphering the mechanisms responsible for invasive tumors along the nerves and the influence of cellular environment on the development of cancer. This occurs in Pancreatic, Head and Neck, Breast, Brain and Prostate Cancer patients.
Cancer invasion leads to the spreading of the tumor, pain and functional disorder. The tumor usually cannot be removed at the time of diagnosis, and without therapy, the mortality rate is high.
Prof. Gil's research is directed towards developing of new treatment modalities for these patients. |
|
| |
Dr. Lior Dayan: The Relationship Between the Autonomic Nervous System Function and Nerve Pain
|
Specialties/ Sub Specialties: Pain, Orthopedic Surgery.
About the Research:
The research examines the relationship between the autonomic nervous system function and nerve pain.
The Autonomic nervous system controls the internal environment of the body and keeps it balanced. (For example: heart rate, blood pressure, regulated body temperature)
The activation of the autonomic nervous system may contribute to certain forms of reduction in pain in patients who suffer from chronic nerve pain.
|
|
| |
Dr. Nicola J. Mabjeesh: Understanding the Mechanism of Cancer Cell Survival Under Conditions of Hypoxia (Low Oxygen Levels)
|
Dr. Mabjeesh is an expert in Urological Surgery; He is the Deputy Chairman of the Department of Urology and Director of the Prostate Cancer Research Laboratory.
Specialties/ Sub Specialties: Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.
About the Research:
The lab work focuses on two types of research-Translational Research and Clinical Research.
The aim of the research is to understand the mechanisms of how cancer cells survive under conditions of low oxygen levels and to develop new ways to overcome them, and to “translate” the answers into clinical applications.
The point of the research is combining basic scientific research with clinical research. |
|
| |
Dr. Eli Rimon: The Effect of Heparin on the Physiology of the Placenta and the Implications for Treatment and Prevention of Complications of Pregnancy
Dr. Rimon is a Senior Doctor in the Prenatal Care Unit, Head of the High Risk Pregnancy Clinic.
Specialties/ Sub Specialties: Specializes in Obstetrics and Gynecology in “Lis”, Sub Specializes in High Risk Pregnancy and Placental Research in Washington University in the United States.
About the Research:
Pregnant women with hypercoaguablility states and previous pregnancy complications are routinely treated today with anti-coagulant medicine called low molecular Heparin (LMWH). Using this treatment we reduced the incidence of pregnancy complications, however, the mechanism by which LMWH improves pregnancy outcome is not known. The research focuses on the effect of LMWH on the physiology of the placenta, including differentiation and resistance to cell death, and the implications for treatment and prevention of pregnancy complications. |
March
2011
|
| |